Project
RICE: An open label, randomized study to compare the efficacy of Certolizumab pegol (CZP) plus a dynamic or fixed dose treatment strategy in patients with Rheumatoid Arthritis, a phase II study
Completed · 2014 until 2018
Müller Rüdiger, Forrer Silvia, Bartz-Batliner Mira, Schmidig Kathrin, Hutz Carina Liane
Type
Clinical Studies
Range
Multicentric, KSSG as main centre
Units
Status
Completed
Start Date
2014
End Date
2018
Financing
Others
Keywords
fortgeschrittene RA, Gelenksinfiltration, Certolizumab
Brief description/objective
randomisierte Studie bei fortgeschrittener rheumatoider Arthritis mit Certolizumab, Standardtherapie DMARD/Prednison plus Certolizumab vs Therapieeskalation DMARD/Prednison mit Certolizumab und Gelenksinfiltration.